Skip to main content
John Berdahl, MD, Ophthalmology, Sioux Falls, SD

JohnPalmerBerdahlMD

Ophthalmology Sioux Falls, SD

Cataract Related

Physician

Dr. Berdahl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Berdahl's full profile

Already have an account?

  • Office

    3101 W 57th St
    Sioux Falls, SD 57108
    Phone+1 605-361-3937
    Fax+1 605-371-7199

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Ophthalmology, 2005 - 2008
  • Mayo Clinic College of Medicine and Science
    Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2004 - 2005
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 2004

Certifications & Licensure

  • MT State Medical License
    MT State Medical License 2021 - 2025
  • SD State Medical License
    SD State Medical License Active through 2025
  • ND State Medical License
    ND State Medical License 2014 - 2024
  • IA State Medical License
    IA State Medical License 2009 - 2019
  • IL State Medical License
    IL State Medical License 2014 - 2015
  • MN State Medical License
    MN State Medical License 2008 - 2013
  • NC State Medical License
    NC State Medical License 2005 - 2008
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • FDA Grants DeNovo Classification to Balance Ophthalmics' FYSX Ocular Pressure Adjusting Pump
    FDA Grants DeNovo Classification to Balance Ophthalmics' FYSX Ocular Pressure Adjusting PumpJune 28th, 2024
  • Aldeyra Therapeutics Achieves Primary Endpoints in Dry Eye Disease Chamber Crossover Clinical Trial
    Aldeyra Therapeutics Achieves Primary Endpoints in Dry Eye Disease Chamber Crossover Clinical TrialJuly 13th, 2022
  • Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
    Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021July 22nd, 2021
  • Join now to see all

Professional Memberships